HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,633-1,644 of 1,811
Device study icon
CompletedACTRN12623000511639

Treating listening difficulties in children with attention challenges

Official study title

A randomised controlled trial investigating the use of remote microphone technology to manage listening difficulties in children with attention deficits

This study has finished and is no longer accepting participants.

In Parkville
ADHDInterventional studyAges 6–12
Countries
Australia
Sponsor
University of Melbourne
Drug study icon
TerminatedEUCTR 2018-001166-42

A multi-centre, randomized, parallel-group, single blind Phase II trial to evaluate the pharmacokinetics and PKPD relationship of trazodone after single and repeated oral doses in children from 2 t...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Italy
ADHDHistorical research record
Countries
Italy, Spain
Sponsor
Aziende Chimiche Riunite Angelini Francesco ACRAF S.p.A (Angelini S.p.A.)
Drug study icon
CompletedEUCTR 2009-018161-12

A Phase 3, Double-blind, Placebo-controlled, Multicentre, Randomised withdrawal, Long-term Maintenance of Efficacy and Safety Study of Extended-release Guanfacine Hydrochloride in Children and Adol...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
ADHDHistorical research record
Countries
United Kingdom, Belgium, Germany, + 4 others
Sponsor
Shire Development Inc
Drug study icon
CompletedNCT00421603

Mixed Amphetamine Salts and Topiramate for ADHD

Official study title

A Randomized, Double-Blind, Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence

This study has finished and is no longer accepting participants.

In New York
ADHDMedication studyAges 18–60
Countries
United States
Sponsor
New York State Psychiatric Institute
Other study type icon
CompletedNCT02250339

A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric Disorders

Official study title

Phase 2: A Prospective Observational Study of Feasibility and Tentative Effectiveness of Multi-Systemic and Multicomponent Family-Based Intervention for Families of Children With Neuropsychiatric and/or Psychiatric Disorder(s).

This study has finished and is no longer accepting participants.

In Helsinki
ADHDObservational studyAges 5–12
Countries
Finland
Sponsor
Social Insurance Institution, Finland
Drug study icon
CompletedNCT00236444

Risperidone for ADHD

Official study title

Risperidone in the Prevention of Relapse: a Randomized, Double-blind, Placebo-controlled Trial in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders.

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 5–17
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT00250354

Effectiveness of risperidone in ADHD

Official study title

The Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 5–12
Countries
Sponsor
Janssen Pharmaceutica N.V., Belgium

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.